Month: January 2019

Adaptive Biotechnologies to enter into a worldwide collaboration and license agreement with Genentech to develop personalized cell therapies for the treatment of cancer

SEATTLE – (COMMERCIAL THREAD) – Adaptive Biotechnologies, an immunological medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech, a member of the Roche Group, to develop, manufacture and commercialize novel cell-based therapies T directed by neoantigens for the treatment of a wide range of cancers. The collaboration […]

Back To Top